Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations 
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says 
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend 
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth 
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
SK Telecom Co. has released a mobile app-based DNA testing service dubbed care8 DNA in partnership with its joint venture Invites Healthcare Co. and bio firm Macrogen Inc.
The subscription-based setting allows users to sign up for 29 types of genetic testing, such as for nicotine reliance and hair loss.
Users will receive DNA test kits at home, which they would send back to SK Telecom with their saliva for analysis.
Test results will be available on the care8 DNA app after two weeks.
According to SK Telecom, their DNA service, which costs 99,000 won for a one-year subscription, is more affordable than local direct-to-consumer (DTC) genetic tests.
The app also provides other services, such as personalized health coaching. More genetic tests would also be introduced.
SK Telecom, South Korea's largest mobile carrier, increased its investment in Israel-based startup Nano-X Imaging Ltd in June to boost its presence in the digital health care sector.
The global DTC genetic testing market is expected to increase to $6.4 billion in 2028 from $824 million in 2018.
